
The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
The program includes various presentations on scientific and regulatory affairs.
By way of its Beneo-Institute for scientific and regulatory research, the Beneo Group will host a second European Scientific Symposium, specifically focusing on
Beneo’s symposium will feature presentations from academic experts on emerging science and regulatory approaches to these food ingredient categories, including:






